Tag: Cancer: Skin
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma
Consistent survival benefit seen across several prespecified subgroups, including those with a BRAF V600E mutation
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
Neoadjuvant treatment followed by surgery results in longer event-free survival for resectable, macroscopic stage III melanoma
Non-Hispanic Black Melanoma Patients Present With Advanced Disease
T category and stage at presentation higher for non-Hispanic Black patients
Second Primary Malignancy Risk Increased After Cutaneous B-Cell Lymphoma
Women have increased risk for thyroid, renal, lung cancers; men have highest risk for melanoma, bladder, prostate cancers
AAD: Concerns Noted Relating to Use of AI Dermatology Apps
None of the apps are approved by the FDA; only two include disclaimers for lack of regulatory approval
Delayed Melanoma Care During Pandemic Proved Costly
Delayed diagnoses due to pandemic lockdowns tied to years of life lost
Amtagvi Approved by the FDA for Treatment of Advanced Melanoma
Agency approves one-time cell therapy for patients who have progressed after initial standard-of-care therapies
Smoking Linked to Melanoma-Associated Death in Early-Stage Melanoma
Greatest increased risk for melanoma-specific mortality seen for patients with SLNB-negative disease
Gender Minority Adults Are Vulnerable During Full Body Skin Exam
Gender queer and transgender individuals more likely to report discomfort than sexual minority cisgender females, males
Early FDG PET/CT Can ID Metabolic Changes in Advanced Melanoma
Metabolic changes associated with progression-free survival in patients receiving pembrolizumab
